-
Mashup Score: 0Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment - Charles Link, MD - 10 day(s) ago
Dive into the SYNC-T technology by Syncromune® Inc. and its groundbreaking approach to hormone-refractory prostate cancer. Learn how it stimulates an immune response within the tumor microenvironment and adjacent lymph nodes.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies - Elias Jabbour, MD - 10 day(s) ago
Introduction to Emerging Therapies in ALL Management … Dr. Elias Jabbour shared recent developments in the treatment of acute lymphoblastic leukemia (ALL) during a recent medical conference. His presentation focused on the evolving landscape of ALL therapy, particularly emphasizing the growing importance of targeted therapies including bispecific antibodies, antibody-drug conjugates (ADCs), and tyrosine kinase inhibitors
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Dr. Scott Kopetz discussed the KRYSTAL-1 study at AACR, presenting promising results of combining adagrasib and cetuximab to target KRASG12C mutated colorectal cancer, reporting a 34% response rate, with progression-free survival of 6.9 months and overall survival of 15.9 months in heavily pretreated patients.
Source: videos.oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Ajay Goel, PhD - Exosome Biopsy Detects Pancreatic Cancer - 18 day(s) ago
Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a diagnostic accuracy of 92-97%. This approach, unique for its use of both cell-free and exosomal microRNAs, was validated across multiple international cohorts.
Source: videos.oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Ajay Goel, PhD - Exosome Biopsy Detects Pancreatic Cancer - 18 day(s) ago
Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a diagnostic accuracy of 92-97%. This approach, unique for its use of both cell-free and exosomal microRNAs, was validated across multiple international cohorts.
Source: videos.oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Revolutionizing Pancreatic Cancer Detection: The Groundbreaking Role of Liquid Biopsies - Ajay Goel, PhD [AACR 2024] - 18 day(s) ago
Uncover a revolutionary approach to pancreatic cancer detection. Delve into the study’s methodology and learn how microRNAs are used in liquid biopsies for unparalleled accuracy.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Targeting SCD1 in KRAS Mutant Non-Small Cell Lung Cancer: A Novel Therapeutic Strategy - 20 day(s) ago
Uncover the impact of SCD1 in NSCLC with concurrent KRAS, STK11, and KEAP1 mutations. Learn about the potential of SCD1 as a novel therapeutic target for overcoming treatment resistance in lung cancer.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Learn about the remarkable response rate and complete response rate of Lenvosiltamab in multiple myeloma patients. Explore this potential paradigm shift in treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14
Find out how combining traditional chemotherapies with Lurbinectedin can improve outcomes in small cell lung cancer. Discover the therapeutic potential of this innovative treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Efficacy and Safety of Inotuzumab Ozogamicin - MOASC 2024 - 2 month(s) ago
Mojtaba Akhtari, MD, FACP-Professor of Medicine-Loma Linda University explains the Efficacy and Safety of Inotuzumab Ozogamicin – from the MOASC 2024 Advances in Oncology meeting in Newport B
Source: videos.oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
Overview of SYNC-T Technology from @syncromune in Prostate Cancer Treatment – Charles Link, MD Watch Video: https://t.co/RN0GIBrD0h #AACR24 #EndCancer #ProstateCancer https://t.co/GVu17hSzBB